The Progressive Supranuclear Palsy Clinical Deficits Scale

Background There is currently no undisputed, validated, clinically meaningful measure for deficits in the broad spectrum of PSP phenotypes. Objective To develop a scale to monitor clinical deficits in patients with PSP across its broad phenotypes. Methods The Progressive Supranuclear Palsy Clinical Deficits Scale was conceptualized to cover seven clinical domains ( A kinesia‐rigidity, B radyphrenia, C ommunication, D ysphagia, E ye movements, F...